Ceftriaxone: A Suspected Cause for Increased Hepatic Transaminases and Blood Urea Nitrogen
Asian Journal of Pharmaceutical and Health Sciences · 2022
DOI: 10.5530/ajphs.2021.11.24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Pharmaceutical and Health Sciences, 2022. Verfasst von S.K Jareena.
Abstract (Originalsprache)
Ceftriaxone is a third-generation cephalosporin antibiotic that has been associated with the development of biliary sludge and biliary colic when given parenterally and in high doses. Ceftriaxone is also associated with rare instances of immune allergic, usually cholestatic hepatitis similar to the injury associated with other cephalosporins. The parenteral cephalosporins are widely used in medicine for serious infections and can be safely given to patients with advanced liver disease, dose modifications being required mainly for renal insufficiency. Previous studies have reported a few cases of high aspartate aminotransferase and alanine aminotransferase levels, along with three cases of hepatitis caused by ceftriaxone.
Zitieren
APA
Jareena, S. (2022). Ceftriaxone: A Suspected Cause for Increased Hepatic Transaminases and Blood Urea Nitrogen. Asian Journal of Pharmaceutical and Health Sciences. https://doi.org/10.5530/ajphs.2021.11.24
Vancouver
Jareena S. Ceftriaxone: A Suspected Cause for Increased Hepatic Transaminases and Blood Urea Nitrogen. Asian Journal of Pharmaceutical and Health Sciences. 2022. doi:10.5530/ajphs.2021.11.24
BibTeX
@article{Jareena2022,
author = {Jareena, S.K},
title = {Ceftriaxone: A Suspected Cause for Increased Hepatic Transaminases and Blood Urea Nitrogen},
journal = {Asian Journal of Pharmaceutical and Health Sciences},
year = {2022},
doi = {10.5530/ajphs.2021.11.24}
}
EUVIMED